Source: FASEB BioAdvances. Unidade: FMRP
Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI, LECTINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIGUEL, Camila Botelho et al. Administration of artinm lectin reduces the severity of the acute phase infection with Trypanosoma cruzi. FASEB BioAdvances, v. 3, n. 5, p. 295-304, 2021Tradução . . Disponível em: https://doi.org/10.1096/fba.2020-00065. Acesso em: 17 out. 2024.APA
Miguel, C. B., Silva, T. A. da, Rodrigues, W. F., Brito, P. K. M. O., Roque-Barreira, M. C., & Chica, J. E. L. (2021). Administration of artinm lectin reduces the severity of the acute phase infection with Trypanosoma cruzi. FASEB BioAdvances, 3( 5), 295-304. doi:10.1096/fba.2020-00065NLM
Miguel CB, Silva TA da, Rodrigues WF, Brito PKMO, Roque-Barreira MC, Chica JEL. Administration of artinm lectin reduces the severity of the acute phase infection with Trypanosoma cruzi [Internet]. FASEB BioAdvances. 2021 ; 3( 5): 295-304.[citado 2024 out. 17 ] Available from: https://doi.org/10.1096/fba.2020-00065Vancouver
Miguel CB, Silva TA da, Rodrigues WF, Brito PKMO, Roque-Barreira MC, Chica JEL. Administration of artinm lectin reduces the severity of the acute phase infection with Trypanosoma cruzi [Internet]. FASEB BioAdvances. 2021 ; 3( 5): 295-304.[citado 2024 out. 17 ] Available from: https://doi.org/10.1096/fba.2020-00065